drugset / Trial / NCT00036309

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

NCT00036309

Phase 3 Completed Eli Lilly and Company
Treatment

Summary

The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.

Timeline

Start
2002-05
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg

Indications